| Literature DB >> 23304549 |
Hiroya Utsumi1, Hiroo Terashi, Yohei Ishimura, Tomoko Takazawa, Yasuyuki Okuma, Mitsuru Yoneyama, Hiroshi Mitoma.
Abstract
In advanced-stage Parkinson's disease (PD), motor fluctuation is a frequent and disabling problem. Assessment of motor fluctuation depends on patient's subjective self-statement. We examined whether the subjective fluctuation matched the objective motor fluctuation defined by gait disorders. Using a new device, the portable gait rhythmogram, we recorded gait cadence and acceleration continuously over the 24-hour period in 54 patients with PD and 17 normal controls, for the quantitative evaluation of motor fluctuation. The patients were asked to estimate motor fluctuation every hour. In 44 of 54 patients, changes in the cadence were associated with simultaneous changes in acceleration. We examined the subjective fluctuation in these 44 patients who were confirmed to have motor fluctuation. Nineteen (82.7%) of 23 patients who felt no fluctuation showed distinct gait disorders. During off time, they walked with marked short or bradykinetic stepping. No matching changes were observed in either the cadence or acceleration in 11 (52.4%) of 21 patients who perceived motor fluctuation. No synchronization was noted in 30 (68.2%) of the 44 patients, between the times of subjectively assessed motor fluctuation and those of quantitative analysis of gait disorder. This discrepancy suggests that the objective continuous recording of the cadence and acceleration is necessary to understand motor fluctuation.Entities:
Year: 2012 PMID: 23304549 PMCID: PMC3530791 DOI: 10.5402/2012/372030
Source DB: PubMed Journal: ISRN Neurol ISSN: 2090-5505
Clinical features of patients with Parkinson's disease.
| Case no. | Age (years) | Gender | Duration (years) | M H-Y | UPDRS Part III | Medication | |||
|---|---|---|---|---|---|---|---|---|---|
| Total score | Gait | Postural stability | Bradykinesia | ||||||
| Subjective good | |||||||||
|
| |||||||||
| 1 | 73 | M | 3.6 | 3 | 12 | 1 | 2 | 2 | L-dopa 300 mg, Ama 200 mg |
| 2 | 73 | M | 3.6 | 3 | 12 | 1 | 2 | 2 | L-dopa 300 mg, Ama 200 mg |
| 3 | 79 | M | 1.3 | 3 | 44 | 2 | 2 | 2 | L-dopa 300 mg |
| 4 | 70 | F | 2.8 | 3 | 11 | 1 | 2 | 1 | L-dopa 300 mg, Pra 1.5 mg |
| 5 | 55 | M | 2.5 | 2 | 11 | 0 | 0 | 0 | Rop 4 mg, Ama 200 mg |
| 6 | 70 | F | 3.6 | 2.5 | 9 | 1 | 1 | 1 | L-dopa 300 mg |
| 7 | 75 | M | 3.0 | 3 | 23 | 1 | 2 | 2 | None |
| 8 | 64 | F | 2.6 | 3 | 16 | 2 | 1 | 1 | Rop 2 mg, Ama 200 mg |
| 9 | 73 | F | 7.7 | 1.5 | 10 | 0 | 0 | 0 | L-dopa 300 mg, Pra 3 mg, Ama 100 mg |
| 10 | 83 | M | 3.7 | 2 | 12 | 2 | 0 | 1 | Ama 100 mg |
| 11 | 63 | F | 0.5 | 2 | 23 | 1 | 0 | 1 | None |
| 12 | 76 | M | 3.1 | 2 | 16 | 0 | 0 | 0 | L-dopa 300 mg |
| 13 | 79 | M | 3.5 | 3 | 34 | 1 | 2 | 2 | L-dopa 300 mg |
| 14 | 79 | M | 3.5 | 2.5 | 29 | 1 | 1 | 2 | L-dopa 200 mg, Tri 4 mg |
| 15 | 78 | M | 8.3 | 2 | 11 | 0 | 0 | 0 | None |
| 16 | 79 | M | 3.8 | 3 | 23 | 1 | 2 | 1 | L-dopa 300 mg, Pra 1.5 mg |
| 17 | 78 | M | 2.9 | 2.5 | 14 | 1 | 1 | 1 | L-dopa 300 mg |
| 18 | 75 | F | 2.4 | 3 | 35 | 2 | 2 | 2 | L-dopa 300 mg, Pra 1.0 mg |
| 19 | 77 | M | 17.6 | 3 | 30 | 2 | 1 | 3 | Pra 2.0 mg, Ama 100 mg |
| 20 | 75 | M | 11.7 | 3 | 26 | 1 | 2 | 2 | L-dopa 300 mg |
| 21 | 64 | M | 1.8 | 1.5 | 10 | 0 | 1 | 1 | L-dopa 300 mg, Pra 1.5 mg |
| 22 | 63 | F | 1.3 | 2 | 21 | 0 | 0 | 1 | None |
| 23 | 63 | F | 1.4 | 2 | 19 | 0 | 0 | 1 | Pra 2 mg |
|
| |||||||||
| Subjective not good | |||||||||
|
| |||||||||
| 24 | 76 | M | 17.3 | 3 | 36 | 2 | 2 | 3 | Ama 100 mg |
| 25 | 67 | M | 3.3 | 2 | 30 | 1 | 1 | 1 | L-dopa 300 mg, Ama 200 mg |
| 26 | 71 | M | 3.4 | 3 | 29 | 1 | 1 | 1 | L-dopa 300 mg, Rop 4 mg |
| 27 | 69 | M | 1.0 | 3 | 17 | 1 | 2 | 2 | None |
| 28 | 59 | M | 9.0 | 2 | 15 | 0 | 0 | 1 | L-dopa 300 mg, Pra 3 mg, Sel 5 mg, Ama 200 mg |
| 29 | 77 | M | 2.8 | 2.5 | 21 | 1 | 1 | 1 | L-dopa 400 mg |
| 30 | 82 | M | 3.9 | 4 | 31 | 2 | 1 | 2 | L-dopa 300 mg, Rop 3 mg |
| 31 | 64 | M | 1.5 | 1.5 | 8 | 0 | 0 | 1 | L-dopa 300 mg |
| 32 | 79 | M | 7.7 | 3 | 21 | 2 | 1 | 1 | L-dopa 400 mg, Per 1.25 mg, Sel 5 mg |
| 33 | 78 | F | 2.0 | 3 | 31 | 1 | 2 | 3 | None |
| 34 | 81 | F | 8.2 | 3 | 17 | 1 | 2 | 2 | L-dopa 300 mg, Rop 2 mg |
| 35 | 65 | F | 3.3 | 2.5 | 19 | 1 | 2 | 2 | Pra 1 mg, Ama 200 mg |
| 36 | 77 | F | 9.6 | 2.5 | 23 | 1 | 1 | 1 | L-dopa 300 mg, Rop 2 mg |
| 37 | 56 | F | 2.3 | 3 | 18 | 1 | 2 | 2 | L-dopa 300 mg, Rop 9 mg, Ama 200 mg |
| 38 | 73 | F | 0.5 | 3 | 11 | 0 | 2 | 1 | None |
| 39 | 74 | F | 2.3 | 3 | 35 | 2 | 2 | 2 | L-dopa 300 mg |
| 40 | 70 | F | 2.8 | 3 | 14 | 1 | 2 | 1 | L-dopa 300 mg |
| 41 | 66 | F | 2.7 | 2.5 | 15 | 1 | 1 | 1 | L-dopa 200 mg, Rop 6 mg |
| 42 | 72 | M | 8.3 | 3 | 24 | 1 | 1 | 1 | L-dopa 400 mg, Rop 5 mg |
| 43 | 65 | M | 1.7 | 1.5 | 10 | 1 | 0 | 0 | Tri 4 mg |
| 44 | 64 | F | 12.8 | 3.5 | 21 | 1 | 2 | 1 | L-dopa 500 mg, Pra 4 mg, Ent 500 mg |
M H-Y: modified Hoehn and Yahr stage, UPDRS: unified Parkinson's disease rating scale, gait: “gait” score, postural stability: “postural stability” score, bradykinesia: “body bradykinesia and hypokinesia” score, Ama: amantadine, Pra: pramipexole, Rop: ropinirole, Tri: trihexyphenidyl, Sel: selegiline, Ent: entacapone, subjective good: patients who did not notice wearing off, and subjective wearing off: patients who noticed subjectively wearing off.
Figure 1Serial changes in gait cadence and acceleration during daily activities. Examples of patients who showed fluctuation in the cadence. Left ordinate: the cadence (black continuous line and symbols), right ordinate: acceleration (red continuous line and symbols), abscissa: time, black dotted line: mean cadence ± 1SD of normal subjects, and red dotted line: mean acceleration − 2SD of normal subjects. The patients in (a), (b), and (c) showed synchronized fluctuations in cadence and acceleration, whereas patient in (d) showed desynchronization.
Figure 2Serial changes in gait cadence and acceleration during daily activities. Examples of patients who showed no fluctuation in the cadence. Left ordinate: the cadence (black continuous line and symbols), right ordinate: acceleration (red continuous line and symbols), abscissa: time, black dotted line: mean cadence ± 1SD of normal subjects, and red dotted line: mean acceleration − 2SD of normal subjects. Fluctuations in acceleration were small in the patient shown in (a), and large in the patient shown in (b).
Comparison between gait off and subjective off.
| Case no. | Gait off time | Subjective off time | Synchronization |
|---|---|---|---|
| Subjective good | |||
|
| |||
| 1 | Good | Good | Both good |
| 2 | Good | Good | Both good |
| 3 | Good | Good | Both good |
| 4 | Good | Good | Both good |
| 5 | 0600 | Good | No |
| 6 | 0800 | Good | No |
| 7 | 1600 | Good | No |
| 8 | 1900 | Good | No |
| 9 | 0400, 0500 | Good | No |
| 10 | 0700, 1600 | Good | No |
| 11 | 0200, 1900 | Good | No |
| 12 | 2200, 2300 | Good | No |
| 13 | 1000, 1300, 1800 | Good | No |
| 14 | 1000, 1100, 1600 | Good | No |
| 15 | 0100, 2000, 2100 | Good | No |
| 16 | 1400, 1600, 1800, 2200 | Good | No |
| 17 | 0600, 1700, 1900, 2000 | Good | No |
| 18 | 0800, 0900, 1800, 2100 | Good | No |
| 19 | 0500, 0700, 0800, 2000 | Good | No |
| 20 | 0100, 0800, 1700, 1800, 2100 | Good | No |
| 21 | 0800, 0900, 1800, 2100, 2400 | Good | No |
| 22 | 0600, 0800, 0900, 1200, 1300, 1800, 1900, 2000, 2100 | Good | No |
| 23 | 0500, 0600, 0700, 0800, 1200, 1800, 1900, 2000, 2100, 2200 | Good | No |
|
| |||
| Subjective wearing off | |||
|
| |||
| 24 | 0800 | 0800, 2100 | Both off at 0800 |
| 25 | 1300 | 1200, 1300, 1600 | Both off at 1300 |
| 26 | 1700, 1800 | 1600, 1700 | Both off at 1700 |
| 27 | 0800, 0900, 1400 | 0600, 0700, 0800, 0900, 1000, 1100, 1200 | Both off at 0800, 0900 |
| 28 | 0600, 0700, 01500 | 1400, 1500, 1600, 1800 | Both off at 1500 |
| 29 | 1500, 1800, 1900 | 0600, 0700, 1300, 1400, 1800, 1900, 2000, 2100, 2200 | Both off at 1800, 1900 |
| 30 | 0200, 0800, 1200, 1300 | 0800 | Both off at 0800 |
| 31 | 0800, 0900, 1500, 1700, 1900, 2000, 2400 | 0900, 1000, 1100, 1300 | Both off at 0900 |
| 32 | 0100, 0300, 0800, 1700, 1900, 2000 | 0800 | Both off at 0800 |
| 33 | 0700, 0800, 0900, 1100, 1200, 1700, 1800, 1900, 2000, 2100 | 0800, 1200, 1400, 1500, 1800, 1900, 2000, 2100, 2200 | Both off at 1200, 1800, 2000, 2100 |
| 34 | Good | 0900, 1000, 1100, 1700, 1800, 1900 | No |
| 35 | Good | 1200, 1300, 1400, 1500 | No |
| 36 | Good | 1600 | No |
| 37 | 1500 | 1000, 1100, 1800, 1900 | No |
| 38 | 1800 | 15 | No |
| 39 | 2000 | 13, 14, 15 | No |
| 40 | 0100, 0700, 0800 | 11, 12, 13, 17, 18, 19, 23 | No |
| 41 | 0800, 0900, 1400 | 16, 17, 18, 19, 20 | No |
| 42 | 0100, 0400, 1300, 2300 | 5, 7, 15, 16, 17, 19, 20, 21 | No |
| 43 | 0400, 0600, 0700, 1500 | 18 | No |
| 44 | 0300, 0600, 0700, 1600 | 12, 13 | No |
Gait off time: the time when the gait off was recorded. Subjective off time: the time when the subjective gait off was noticed. Subjective good: patients who did not notice wearing off. Subjective wearing off: patients who noticed subjective wearing off.
Figure 3Comparison between gait fluctuation (top) and subjective fluctuation (bottom). Examples of patients who subjectively felt no motor fluctuation. Top: serial changes in gait cadence and acceleration during daily activities. Left ordinate: the cadence (black continuous line and symbols), right ordinate: acceleration (red continuous line and symbols), abscissa: time, black dotted line: mean cadence ± 1SD of normal subjects, red dotted line: mean acceleration − 2SD of normal subjects. The determined gait off is indicated by black rectangle below the top figure. The lack of awareness of motor fluctuation was in agreement with the lack of recorded changes in gait fluctuation in (a), where the two sets of data were in disagreement in (b).
Figure 4Comparison between gait fluctuation (top) and subjective fluctuation (bottom). Examples of patients who reported motor fluctuations. Top: serial changes in gait cadence and acceleration during daily activities. Left ordinate: the cadence (black continuous line and symbols), right ordinate: acceleration (red continuous line and symbols), abscissa: time, black dotted line: mean cadence ± 1SD of normal subjects, red dotted line: mean acceleration − 2SD of normal subjects. The determined gait off is indicated by black rectangle below the top figure. Awareness of motor fluctuation was in agreement with the recorded changes in gait fluctuation in (a) and (b), but not in (c) and (d).